Clinical Trial Update: Buspirone Therapy for Localized Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial of buspirone for localized epilepsy has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Epilepsy
• Seizures

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Anxiety Disorder, Seizures | Phase 2 | Status: TERMINATED | Results posted: 2021-09-05